• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Performance of five FDA-approved rapid antigen tests in the detection of 2009 H1N1 influenza A virus

tetano

Editor, Senior Moderator
J Med Virol. 2012 Nov;84(11):1699-702. doi: 10.1002/jmv.23374.
Performance of five FDA-approved rapid antigen tests in the detection of 2009 H1N1 influenza A virus.
Sutter DE, Worthy SA, Hensley DM, Maranich AM, Dolan DM, Fischer GW, Daum LT.
Source

Department of Pediatrics, San Antonio Military Medical Center, Ft Sam Houston, Texas. deena.sutter@amedd.army.mil.
Abstract

Rapid antigen tests are commonly used by clinicians for rapid, simple, point-of-care testing. Five rapid antigen tests were shown to have low sensitivity (40.3-58.8%) when compared to real-time RT-PCR using nasal wash specimens from patients with influenza-like-illness (N = 167) that were collected previously and confirmed as 2009 pandemic influenza A (H1N1)-positive by PCR. Rapid antigen test sensitivity correlated with virus levels in nasal secretions when comparisons were made to cycle threshold (C(T) ) values obtained from real-time RT-PCR. When C(T) values are <25 (equating to viral concentrations of >10(4)  TCID(50) /ml) sensitivity for all five rapid antigen kits was high (range: 83-94% positive); however, when C(T) values are >30 (10(2)  TCID(50) /ml), sensitivities of only 16-18% were observed for four of five rapid antigen kits. The Directigen EZ Flu A + B test detected more positive samples (35%) at lower viral concentrations with C(T) values >30 when compared with other commercial kits (P = 0.05). Rapid antigen test results must be interpreted with caution, and negative specimens may need confirmation by sensitive molecular assays. J. Med. Virol. 84:1699-1702, 2012. ? 2012 Wiley Periodicals, Inc.

Copyright ? 2012 Wiley Periodicals, Inc.

PMID:
22997071
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/22997071
 
Back
Top Bottom